Cytosorbents
CTSO
#9826
Rank
NZ$79.23 M
Marketcap
NZ$1.26
Share price
-1.20%
Change (1 day)
-16.29%
Change (1 year)

Cytosorbents (CTSO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$62.9 Million

According to Cytosorbents's latest financial reports the company's total liabilities are NZ$62.9 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cytosorbents - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$64.3 M37.96%
2023-12-31NZ$46.6 M6.23%
2022-12-31NZ$43.87 M11.24%
2021-12-31NZ$39.44 M165.11%
2020-12-31NZ$14.87 M-58.19%
2019-12-31NZ$35.58 M38.27%
2018-12-31NZ$25.73 M32.05%
2017-12-31NZ$19.48 M61.54%
2016-12-31NZ$12.06 M171.26%
2015-12-31NZ$4.44 M-22.66%
2014-12-31NZ$5.75 M-74.19%
2013-12-31NZ$22.28 M22.5%
2012-12-31NZ$18.19 M16.25%
2011-12-31NZ$15.64 M425.68%
2010-12-31NZ$2.97 M122.72%
2009-12-31NZ$1.33 M-24.53%
2008-12-31NZ$1.77 M49.58%
2007-12-31NZ$1.18 M-22.92%
2006-12-31NZ$1.53 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Meridian Bioscience
VIVO
NZ$0.16 B 161.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$6.84 B 10,787.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$32.96 B 52,303.58%๐Ÿ‡บ๐Ÿ‡ธ USA